An investigation has commenced on behalf of edwards lifesciences corporation shareholders. contact levi & korsinsky to discuss your ew losses.

New york, ny / accesswire / july 29, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of edwards lifesciences corporation ("edwards lifesciences") (nyse:ew) concerning possible violations of federal securities laws. on october 28, 2022, edwards announced 3q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4q.
EW Ratings Summary
EW Quant Ranking